Idalopirdine Hydrochloride
|
I651193-10mg
|
≥99% |
467458-02-2 |
10mg
|
¥ 3125.9
|
期货,请咨询 |
阿拉丁 |
Impurity C of Alfacalcidol
|
I651144-5mg
|
≥99% |
82266-85-1 |
5mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
Impurity C of Alfacalcidol
|
I651144-1mg
|
≥99% |
82266-85-1 |
1mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
IZCZ-3
|
I651139-5mg
|
≥98% |
2223019-53-0 |
5mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
IZCZ-3
|
I651139-50mg
|
≥98% |
2223019-53-0 |
50mg
|
¥ 19500.9
|
期货,请咨询 |
阿拉丁 |
IZCZ-3
|
I651139-10mg
|
≥98% |
2223019-53-0 |
10mg
|
¥ 6800.9
|
期货,请咨询 |
阿拉丁 |
IZCZ-3
|
I651139-100mg
|
≥98% |
2223019-53-0 |
100mg
|
¥ 29000.9
|
期货,请咨询 |
阿拉丁 |
Incyclinide
|
I651138-5mg
|
≥98% |
15866-90-7 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Incyclinide
|
I651138-50mg
|
≥98% |
15866-90-7 |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
Incyclinide
|
I651138-1mg
|
≥98% |
15866-90-7 |
1mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Incyclinide
|
I651138-10mg
|
≥98% |
15866-90-7 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
IPR-803
|
I651117-5mg
|
≥98% |
892243-35-5 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
IPR-803
|
I651117-50mg
|
≥98% |
892243-35-5 |
50mg
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
IPR-803
|
I651117-25mg
|
≥98% |
892243-35-5 |
25mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
IPR-803
|
I651117-10mg
|
≥98% |
892243-35-5 |
10mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |
Imifoplatin
|
I651096-5mg
|
≥95% |
1339960-28-9 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
Imifoplatin
|
I651096-50mg
|
≥95% |
1339960-28-9 |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
Imifoplatin
|
I651096-25mg
|
≥95% |
1339960-28-9 |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
Imifoplatin
|
I651096-10mg
|
≥95% |
1339960-28-9 |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-Ivosidenib
|
I651034-5mg
|
≥98% |
2070009-31-1 |
5mg
|
¥ 950.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-Ivosidenib
|
I651034-50mg
|
≥98% |
2070009-31-1 |
50mg
|
¥ 5900.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-Ivosidenib
|
I651034-10mg
|
≥98% |
2070009-31-1 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
(R,S)-Ivosidenib
|
I651034-100mg
|
≥98% |
2070009-31-1 |
100mg
|
¥ 9900.9
|
期货,请咨询 |
阿拉丁 |
I-138
|
I651010-5mg
|
|
2098211-50-6 |
5mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |